Medtrum to Preview New S10 CGM at EASD 2026

The 16 mm, 1 g all-in-one CGM updates every 2 minutes and is designed to work with the Nano tubeless insulin pump as part of Medtrum’s compact AID system

MILAN, ITALY, September 22, 2026 /EINPresswire.com/ -- Medtrum will give visitors at EASD 2026 in Milan a first look at its new S10 Continuous Glucose Monitoring (CGM) system, the latest addition to Medtrum’s CGM portfolio and the next step in the evolution of the TouchCare Nano System, Medtrum's connected AID system.

The S10 is small by design. It is circular, measures just 16 mm in diameter and weighs approximately 1 gram. Its all-in-one format brings the CGM components together into a single wearable device, so there is no separate reusable transmitter.

Despite its smaller size, the S10 keeps the core connected experience of Medtrum’s current CGM technology. The S10 offers up to 14 days of wear and provides glucose updates every two minutes. People living with diabetes can also view their glucose data on a compatible smartphone.

The S10 is also designed to work with Medtrum’s Nano Pump, allowing glucose monitoring, tubeless insulin delivery and Medtrum’s algorithm to work together as part of the TouchCare Nano System. Paired with the Nano 200U tubeless insulin pump, it forms a highly compact AID setup with two small, discreet on-body devices and no tubing.

“With S10, we’ve moved the electronics and battery inside the sensor itself, with nothing separate to charge or pair, while keeping the connectivity that is central to our AID system,” said Scott Yang, founder and CEO of Medtrum.

The S10 CGM will be on display at EASD 2026 in Milan from 29 September to 1 October. Visitors can see the new CGM alongside the Nano Pump at Booth H.03 at Allianz MiCo, Milan, and explore Medtrum’s latest work in diabetes technology.


About Medtrum
Medtrum is a global leader in diabetes technology, dedicated to making diabetes care smaller, simpler, and smarter. Medtrum has developed the world’s smallest AID system, CGM and tubeless patch pump, with breakthrough miniaturization designed to make advanced diabetes technology remarkably discreet and comfortable to wear. At the core is our proprietary APGO^® advanced closed-loop artificial pancreas algorithm. Through a simple smartphone app, the system continuously analyzes real-time glucose data and automatically calculates and adjusts insulin delivery, dramatically reducing the need for manual intervention and simplifying everyday diabetes care—giving people with diabetes greater freedom in everyday life. Medtrum products are now available in more than 50 countries and regions and are covered by healthcare reimbursement systems in more than 20 European countries, including the UK, France, Germany, Italy, the Netherlands and the Nordic countries. Medtrum is advancing the next generation of diabetes care.

Jessie Cai
Medtrum Tech Limited
pr@medtrum.com.hk
Visit us on social media:
LinkedIn
X
Instagram
Facebook
YouTube
TikTok